Showing results (171-180 of 307) with videos related to

Sort By:
Pageof 31
The Journal of Experimental Medicine|March 17, 2004
Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonistRutger L van Bezooijen, Bernard A J Roelen, Annemieke Visser, et al.
JAMA|December 16, 2004
Does this woman have osteoporosis?Amanda D Green, Cathleen S Colón-Emeric, Lori Bastian, et al.
British Journal of Clinical Pharmacology|January 17, 2019
Pharmacology of bisphosphonatesSerge Cremers, Matthew T Drake, F Hal Ebetino, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 13, 2006
Wnt but not BMP signaling is involved in the inhibitory action of sclerostin on BMP-stimulated bone formationRutger L van Bezooijen, J Peter Svensson, Daniël Eefting, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|March 14, 2013
Absence of Cx43 selectively from osteocytes enhances responsiveness to mechanical force in miceNicoletta Bivi, Rafael Pacheco-Costa, Lucas R Brun, et al.
Calcified Tissue International|May 25, 2011
Nmp4/CIZ suppresses the response of bone to anabolic parathyroid hormone by regulating both osteoblasts and osteoclastsPaul Childress, Binu K Philip, Alexander G Robling, et al.
Journal of Cellular Biochemistry|April 25, 2007
Nmp4/CIZ contributes to fluid shear stress induced MMP-13 gene induction in osteoblastsKanokwan Charoonpatrapong-Panyayong, Rita Shah, Jieping Yang, et al.
The Journal of Clinical Endocrinology and Metabolism|March 11, 2020
The Impact of Mild Autonomous Cortisol Secretion on Bone Turnover MarkersShobana Athimulam, Danae Delivanis, Melinda Thomas, et al.
Bone Reports|March 23, 2017
Predictors of teriparatide treatment failure in patients with low bone massTarig Elraiyah, Adil H Ahmed, Zhen Wang, et al.
Pageof 31